Leon O. Moulder, Jr. Acquires 5,000 Shares of TESARO Inc (TSRO) Stock
TESARO Inc (NASDAQ:TSRO) CEO Leon O. Moulder, Jr. purchased 5,000 shares of the stock in a transaction dated Friday, March 2nd. The stock was bought at an average cost of $56.93 per share, with a total value of $284,650.00. Following the transaction, the chief executive officer now owns 1,018,828 shares in the company, valued at $58,001,878.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Shares of TESARO Inc (NASDAQ TSRO) opened at $57.68 on Monday. The company has a current ratio of 4.73, a quick ratio of 4.35 and a debt-to-equity ratio of 0.34. TESARO Inc has a 52-week low of $52.20 and a 52-week high of $184.00.
TESARO (NASDAQ:TSRO) last announced its quarterly earnings data on Tuesday, February 27th. The biopharmaceutical company reported ($3.35) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($2.39) by ($0.96). The company had revenue of $48.02 million for the quarter, compared to the consensus estimate of $51.78 million. TESARO had a negative net margin of 222.15% and a negative return on equity of 112.72%. sell-side analysts expect that TESARO Inc will post -9.43 earnings per share for the current fiscal year.
Several large investors have recently made changes to their positions in the stock. Delek Group Ltd. bought a new position in shares of TESARO during the 4th quarter valued at approximately $2,483,000. Iguana Healthcare Management LLC grew its stake in shares of TESARO by 40.0% during the 4th quarter. Iguana Healthcare Management LLC now owns 35,000 shares of the biopharmaceutical company’s stock valued at $2,900,000 after acquiring an additional 10,000 shares during the period. Element Capital Management LLC bought a new position in shares of TESARO during the 4th quarter valued at approximately $16,302,000. Kazazian Asset Management LLC grew its stake in shares of TESARO by 48.8% during the 4th quarter. Kazazian Asset Management LLC now owns 7,806 shares of the biopharmaceutical company’s stock valued at $647,000 after acquiring an additional 2,560 shares during the period. Finally, Macquarie Group Ltd. grew its stake in shares of TESARO by 36.6% during the 4th quarter. Macquarie Group Ltd. now owns 115,354 shares of the biopharmaceutical company’s stock valued at $9,559,000 after acquiring an additional 30,895 shares during the period.
COPYRIGHT VIOLATION WARNING: “Leon O. Moulder, Jr. Acquires 5,000 Shares of TESARO Inc (TSRO) Stock” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/leon-o-moulder-jr-acquires-5000-shares-of-tesaro-inc-tsro-stock/1908931.html.
TESARO, Inc is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.
Receive News & Ratings for TESARO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO and related companies with MarketBeat.com's FREE daily email newsletter.